Mechanisms and markers for hemorrhagic transformation after stroke (original) (raw)

References

1. Asahi M, Asahi K, Wang X, Lo EH (2000) Reduction of tissue plasminogen activator-induced hemorrhage and brain injury by free radical spin trapping after embolic focal cerebral ischemia in rats. J Cereb Blood Flow Metab 20: 452–457
   Article PubMed CAS Google Scholar
2. Bang OY, Buck BH, Saver JL, Alger JR, Yoon SR, Starkman S, Ovbiagele B, Kim D, Ali LK, Sanossian N, Jahan R, Duckwiler GR, Vi~nuela F, Salamon N, Villablanca JP, Liebeskind DS (2007) Prediction of hemorrhagic transformation after recanalization therapy using T2*-permeability magnetic resonance imaging. Ann Neurol 62: 170–176
   Article PubMed Google Scholar
3. Bevilacqua MP (1993) Endothelial-leukocyte adhesion molecules. Annu Rev Immunol 11: 767–804
   Article PubMed CAS Google Scholar
4. Bisdas S, Hartel M, Cheong LH, Koh TS, Vogl TJ (2007) Prediction of subsequent hemorrhage in acute ischemic stroke using permeability CT imaging and a distributed parameter tracer kinetic model. J Neuroradiol 34: 101–108
   Google Scholar
5. Broderick J, Lu M, Jackson C, Pancioli A, Tilley BC, Fagan SC, Kothari R, Levine SR, Marler JR, Lyden PD, Haley EC Jr, Brott T, Grotta JC; NINDS t-PA Stroke Study Group (2001) Apolipoprotein E phenotype and the efficacy of intravenous tissue plasminogen activator in acute ischemic stroke. Ann Neurol 49: 736–744
   Article PubMed CAS Google Scholar
6. Castellanos M, Leira R, Serena J, Blanco M, Pedraza S, Castillo J, Dávalos A (2004) Plasma cellular-fibronectin concentration predicts hemorrhagic transformation after thrombolytic therapy in acute ischemic stroke. Stroke 35: 1671–1676
   Article PubMed CAS Google Scholar
7. Catto AJ, Kohler HP, Bannan S, Stickland M, Carter A, Grant PJ (1998) Factor XIII Val 34 Leu: a novel association with primary intracerebral hemorrhage. Stroke 29: 813–816
   PubMed CAS Google Scholar
8. Chan PH (1996) Role of oxidants in ischemic brain damage. Stroke 27: 1124–1129
   PubMed CAS Google Scholar
9. Cherubini A, Ruggiero C, Polidori MC, Mecocci P (2005) Potential markers of oxidative stress in stroke. Free Radic Biol Med 39: 841–852
   Article PubMed CAS Google Scholar
10. Cocho D, Borrell M, Marti-Fàbregas J, Montaner J, Castellanos M, Bravo Y, Molina-Porcel L, Belvis R, Diaz-Manera JA, Martinez-Domeño A, Martinez-Lage M, Millán M, Fontcuberta J, Marti-Vilalta JL (2006) Pretreatment hemostatic markers of symptomatic intracerebral hemorrhage in patients treated with tissue plasminogen activator. Stroke 37: 996–999
    Article PubMed CAS Google Scholar
11. Dijkhuizen RM, Asahi M, Wu O, Rosen BR, Lo EH (2001) Delayed rt-PA treatment in a rat embolic stroke model: diagnosis and prognosis of ischemic injury and hemorrhagic transformation with magnetic resonance imaging. J Cereb Blood Flow Metab 21: 964–971
    Article PubMed CAS Google Scholar
12. Fernández-Cadenas I, Molina CA, Alvarez-Sabín J, Ribó M, Penalba A, Ortega-Torres L, Delgado P, Quintana M, Rosell A, Montaner J (2006) ACE gene polymorphisms influence t-PA-in-duced brain vessel reopening following ischemic stroke. Neurosci Lett 398: 167–171
    Article PubMed CAS Google Scholar
13. Fernandez-Cadenas I, Alvarez-Sabin J, Ribo M, Rubiera M, Mendioroz M, Molina CA, Rosell A, Montaner J (2007) Influence of thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 gene polymorphisms on tissue-type plasminogen activator-induced recanalization in ischemic stroke patients. J Thromb Haemost 5: 1862–1868
    Article PubMed CAS Google Scholar
14. Fiehler J, Albers GW, Boulanger JM, Derex L, Gass A, Hjort N, Kim JS, Liebeskind DS, Neumann-Haefelin T, Pedraza S, Rother J, Rothwell P, Rovira A, Schellinger PD, Trenkler J; MR STROKE Group (2007) Bleeding risk analysis in stroke imaging before thromboLysis (BRASIL): pooled analysis of T2*-weighted magnetic resonance imaging data from 570 patients. Stroke 38: 2738–2744
    Article PubMed Google Scholar
15. Foerch C, Curdt I, Yan B, Dvorak F, Hermans M, Berkefeld J, Raabe A, Neumann-Haefelin T, Steinmetz H, Sitzer M (2006) Serum glial fibrillary acidic protein as a biomarker for intracerebral haemorrhage in patients with acute stroke. J Neurol Neurosurg Psychiatry 77: 181–184
    Article PubMed CAS Google Scholar
16. Foerch C, Wunderlich MT, Dvorak F, Humpich M, Kahles T, Goertler M, Alvarez-Sabín J, Wallesch CW, Molina CA, Sitzer M, Montaner J (2007) Elevated serum S100B levels indicate a higher risk of hemorrhagic transformation after thrombolytic therapy in acute stroke. Stroke 38: 2491–2495
    Article PubMed CAS Google Scholar
17. Gasche Y, Copin JC, Sugawara T, Fujimura M, Chan PH (2001) Matrix metalloproteinase inhibition prevents oxidative stress-associated blood-brain barrier disruption after transient focal cerebral ischemia. J Cereb Blood Flow Metab 21: 1393–1400
    Article PubMed CAS Google Scholar
18. González-Conejero R, Fernández-Cadenas I, Iniesta JA, Marti-Fabregas J, Obach V, Alvarez-Sabín J, Vicente V, Corral J, Montaner J; Proyecto Ictus Research Group (2006) Role of fibrin-ogen levels and factor XIII V34L polymorphism in thrombolytic therapy in stroke patients. Stroke 37: 2288–2293
    Article PubMed CAS Google Scholar
19. Grotta JC, Chiu D, Lu M, Patel S, Levine SR, Tilley BC, Brott TG, Haley EC Jr, Lyden PD, Kothari R, Frankel M, Lewandowski CA, Libman R, Kwiatkowski T, Broderick JP, Marler JR, Corrigan J, Huff S, Mitsias P, Talati S, Tanne D (1999) Agreement and variability in the interpretation of early CT changes in stroke patients qualifying for intravenous rtPA therapy. Stroke 30: 1528–1533
    PubMed CAS Google Scholar
20. Gürsoy-Ozdemir Y, Can A, Dalkara T (2004) Reperfusion-induced oxidative/nitrative injury to neurovascular unit after focal cerebral ischemia. Stroke 35: 1449–1453
    Article PubMed CAS Google Scholar
21. Hamann GF, del Zoppo GJ, von Kummer R (1999) Hemorrhagic transformation of cerebral infarction-possible mechanisms. Thromb Haemost 82: 92–94
    PubMed Google Scholar
22. Hamann GF Burggraf D, Martens HK, Liebetrau M, Jäger G, Wunderlich N, DeGeorgia M, Krieger DW (2004) Mild to moderate hypothermia prevents microvascular basal lamina antigen loss in experimental focal cerebral ischemia. Stroke 35: 764–769
    Article PubMed Google Scholar
23. Jaillard A, Cornu C, Durieux A, Moulin T, Boutitie F, Lees KR, Hommel M (1999) Hemorrhagic transformation in acute ischemic stroke: The MAST-E study. MAST-E group. Stroke 30: 1326–1332
    PubMed CAS Google Scholar
24. Kassner A, Roberts T, Taylor K, Silver F, Mikulis D (2005) Prediction of hemorrhage in acute ischemic stroke using permeability MR imaging. Am J Neuroradiol 26: 2213–2217
    PubMed Google Scholar
25. Kaur J, Zhao Z, Klein GM, Lo EH, Buchan AM (2004) The neurotoxicity of tissue plasminogen activator? J Cereb Blood Flow Metab 24: 945–963
    Article PubMed CAS Google Scholar
26. Kelly PJ, Morrow JD, Ning M, Koroshetz W, Lo EH, Terry E, Milne GL, Hubbard J, Lee H, Stevenson E, Lederer M, Furie KL (2008) Oxidative stress and matrix metalloproteinase-9 in acute ischemic stroke: the Biomarker Evaluation for Antioxidant Therapies in Stroke (BEAT-Stroke) study. Stroke 39: 100–104
    Article PubMed CAS Google Scholar
27. Kidwell CS, Saver JL, Villablanca JP, Duckwiler G, Fredieu A, Gough K, Leary MC, Starkman S, Gobin YP, Jahan R, Vespa P, Liebeskind DS, Alger JR, Vinuela F (2002) Magnetic resonance imaging detection of microbleeds before thrombolysis: an emerging application. Stroke 33: 95–98
    Article PubMed Google Scholar
28. Knight RA, Barker PB, Fagan SC, Li Y, Jacobs MA, Welch KM (1998) Prediction of impending hemorrhagic transformation in ischemic stroke using magnetic resonance imaging in rats. Stroke 29: 144–151
    PubMed CAS Google Scholar
29. Latour LL, Kang DW, Ezzeddine MA, Chalela JA, Warach S (2004) Early blood-brain barrier disruption in human focal brain ischemia. Ann Neurol 56: 468–477
    Article PubMed Google Scholar
30. Lee SR, Wang X, Tsuji K, Lo EH (2004) Extracellular proteolytic pathophysiology in the neurovascular unit after stroke. Neurol Res 26: 854–861
    Article PubMed CAS Google Scholar
31. Lin K, Kazmi KS, Law M, Babb J, Peccerelli N, Pramanik BK (2007) Measuring elevated microvascular permeability and predicting hemorrhagic transformation in acute ischemic stroke using first-pass dynamic perfusion CT imaging. Am J Neuroradiol 28: 1292–1298
    Article PubMed CAS Google Scholar
32. Liu D, Cheng T, Guo H, Fernández JA, Griffin JH, Song X, Zlokovic BV (2004) Tissue plasminogen activator neurovascular toxicity is controlled by activated protein C. Nat Med 10: 1379–1383
    Article PubMed CAS Google Scholar
33. Montaner J, Molina CA, Monasterio J, Abilleira S, Arenillas JF, Ribó M, Quintana M, Alvarez-Sabin J (2003) Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke. Circulation 107: 598–603
    Article PubMed CAS Google Scholar
34. Montaner J, Fernández-Cadenas I, Molina CA, Monasterio J, Arenillas JF, Ribó M, Quintana M, Chacón P, Andreu AL, Alvarez-Sabín J (2003) Safety profile of tissue plasminogen activator treatment among stroke patients carrying a common polymorphism (C-1562T) in the promoter region of the matrix metalloproteinase-9 gene. Stroke 34: 2851–2855
    Article PubMed CAS Google Scholar
35. Murata Y, Rosell A, Scannevin RH, Rhodes KJ, Wang X, Lo EH (2008) Extension of the thrombolytic time window with mino-cycline in experimental stroke. Stroke (in press)
    Google Scholar
36. Neumann-Haefelin C, Brinker G, Uhlenküken U, Pillekamp F, Hossmann KA, Hoehn M (2002) Prediction of hemorrhagic transformation after thrombolytic therapy of clot embolism: an MRI investigation in rat brain. Stroke 33: 1392–1398
    Article PubMed CAS Google Scholar
37. Nicole O, Docagne F, Ali C, Margaill I, Carmeliet P, MacKenzie ET, Vivien D, Buisson A (2001) The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling. Nat Med 7: 59–64
    Article PubMed CAS Google Scholar
38. NINDS rt-PA Stroke Study Group (1995) Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333: 1581–1587
    Article Google Scholar
39. Ning M, Furie KL, Koroshetz WJ, Lee H, Barron M, Lederer M, Wang X, Zhu M, Sorensen AG, Lo EH, Kelly PJ (2006) Association between tPA therapy and raised early matrix metalloproteinase-9 in acute stroke. Neurology 66: 1550–1555
    Article PubMed CAS Google Scholar
40. Planas AM, Solé S, Justicia C (2001) Expression and activation of matrix metalloproteinase-2 and-9 in rat brain after transient focal cerebral ischemia. Neurobiol Dis 8: 834–846
    Article PubMed CAS Google Scholar
41. Ribo M, Montaner J, Molina CA, Arenillas JF, Santamarina E, Quintana M, Alvarez-Sabin J (2004) Admission fibrinolytic profile is associated with symptomatic hemorrhagic transformation in stroke patients treated with tissue plasminogen activator. Stroke 35: 2123–2127
    Article PubMed CAS Google Scholar
42. Rosell A, Ortega-Aznar A, Alvarez-Sabín J, Fernández-Cadenas I, Ribó M, Molina CA, Lo EH, Montaner J (2006) Increased brain expression of matrix metalloproteinase-9 after ischemic and hemorrhagic human stroke. Stroke 37: 1399–1406
    Article PubMed CAS Google Scholar
43. Rosell A, Cuadrado E, Ortega-Aznar A, Hernández-Guillamon M, Lo EH, Montaner J (2007) MMP-9-positive neutrophil infiltration is associated to blood-brain barrier breakdown and basal lamina type IV collagen degradation during hemorrhagic transformation after human ischemic stroke. Stroke (in press)
    Google Scholar
44. Rosenberg GA, Navratil M, Barone F, Feuerstein G (1996) Proteolytic cascade enzymes increase in focal cerebral ischemia in rat. J Cereb Blood Flow Metab 16: 360–366
    Article PubMed CAS Google Scholar
45. Singer OC, Humpich MC, Fiehler J, Albers GW, Lansberg MG, Kastrup A, Rovira A, Liebeskind DS, Gass A, Rosso C, Derex L, Kim JS, Neumann-Haefelin T; MR Stroke Study Group Investigators (2008) Risk for symptomatic intracerebral hemorrhage after thrombolysis assessed by diffusion-weighted magnetic resonance imaging. Ann Neurol 63:52–60
    Google Scholar
46. Solé S, Petegnief V, Gorina R, Chamorro A, Planas AM (2004) Activation of matrix metalloproteinase-3 and agrin cleavage in cerebral ischemia/reperfusion. J Neuropathol Exp Neurol 63: 338–349
    PubMed Google Scholar
47. Sumii T, Lo EH (2002) Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats. Stroke 33: 831–836
    Article PubMed CAS Google Scholar
48. Suzuki Y, Nagai N, Umemura K, Collen D, Lijnen HR (2007) Stromelysin-1 (MMP-3) is critical for intracranial bleeding after t-PA treatment of stroke in mice. J Thromb Haemost 5: 1732–1739
    Article PubMed CAS Google Scholar
49. Tong DC, Adami A, Moseley ME, Marks MP (2000) Relationship between apparent diffusion coefficient and subsequent hemorrhagic transformation following acute ischemic stroke. Stroke 31: 2378–2384
    PubMed CAS Google Scholar
50. Tong DC, Adami A, Moseley ME, Marks MP (2001) Prediction of hemorrhagic transformation following acute stroke: role of diffusion-and perfusion-weighted magnetic resonance imaging. Arch Neurol 58: 587–593
    Article PubMed CAS Google Scholar
51. Tsuji K, Aoki T, Tejima E, Arai K, Lee SR, Atochin DN, Huang PL, Wang X, Montaner J, Lo EH (2005) Tissue plasminogen activator promotes matrix metalloproteinase-9 upregulation after focal cerebral ischemia. Stroke 36: 1954–1959
    Article PubMed CAS Google Scholar
52. Vo KD, Santiago F, Lin W, Hsu CY, Lee Y, Lee JM (2003) MR imaging enhancement patterns as predictors of hemorrhagic transformation in acute ischemic stroke. Am J Neuroradiol 24: 674–679
    PubMed Google Scholar
53. Wang X, Lee SR, Arai K, Lee SR, Tsuji K, Rebeck GW, Lo EH (2003) Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator. Nat Med 9: 1313–1317
    Article PubMed CAS Google Scholar
54. Wang X, Lo EH (2003) Triggers and mediators of hemorrhagic transformation in cerebral ischemia. Mol Neurobiol 28: 229–244
    Article PubMed CAS Google Scholar
55. Zhang L, Zhang ZG, Zhang RL, Lu M, Adams J, Elliott PJ, Chopp M (2001) Postischemic (6-h) treatment with recombinant human tissue plasminogen activator and proteasome inhibitor PS-519 reduces infarction in a rat model of embolic focal cerebral ischemia. Stroke 32: 2926–2931
    Article PubMed CAS Google Scholar

Download references